Astrana Health (NASDAQ:ASTH) Shares Gap Down – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $27.22, but opened at $25.41. Astrana Health shares last traded at $21.9770, with a volume of 307,490 shares changing hands.

Wall Street Analysts Forecast Growth

ASTH has been the topic of a number of recent analyst reports. Needham & Company LLC initiated coverage on Astrana Health in a research note on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Astrana Health in a report on Monday, December 29th. TD Cowen cut their price target on Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Jefferies Financial Group restated a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Finally, Barclays reduced their target price on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research report on Monday, November 24th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $41.33.

Astrana Health Trading Up 1.9%

The company has a debt-to-equity ratio of 1.27, a current ratio of 1.40 and a quick ratio of 1.40. The stock has a market capitalization of $1.26 billion, a P/E ratio of 115.79, a P/E/G ratio of 0.55 and a beta of 0.87. The firm’s 50 day moving average price is $24.59 and its 200 day moving average price is $26.87.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.46). Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The firm had revenue of $956.05 million for the quarter, compared to the consensus estimate of $952.83 million. During the same period in the previous year, the firm posted $0.33 earnings per share. The business’s revenue was up 99.7% compared to the same quarter last year. As a group, equities research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Signaturefd LLC raised its stake in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after buying an additional 388 shares during the last quarter. GAMMA Investing LLC increased its position in Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares during the last quarter. Covestor Ltd lifted its holdings in Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after acquiring an additional 2,192 shares during the period. Tower Research Capital LLC TRC boosted its position in Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the last quarter. Finally, State of Wyoming purchased a new position in Astrana Health in the second quarter worth about $132,000. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.